Adjustable IOLs—Disrupting the Refractive IOL Industry

D. Chang
{"title":"Adjustable IOLs—Disrupting the Refractive IOL Industry","authors":"D. Chang","doi":"10.17925/USOR.2017.10.02.95","DOIUrl":null,"url":null,"abstract":"A djustable intraocular lenses (IOLs) are uniquely poised to disrupt the refractive IOL arena for both cataract and refractive lens exchange patients. This is because they will not only improve refractive outcomes, but will dramatically enhance the patient experience as well. Patients will be able to postpone confusing decisions about refractive targets and objectives until they can preview them postoperatively. The unique benefit of being able to customize and “choose” their pseudophakic vision after the surgery will be understandable, desirable, and easily explained to family and friends.","PeriodicalId":90077,"journal":{"name":"US ophthalmic review","volume":"10 1","pages":"95"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"US ophthalmic review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/USOR.2017.10.02.95","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

A djustable intraocular lenses (IOLs) are uniquely poised to disrupt the refractive IOL arena for both cataract and refractive lens exchange patients. This is because they will not only improve refractive outcomes, but will dramatically enhance the patient experience as well. Patients will be able to postpone confusing decisions about refractive targets and objectives until they can preview them postoperatively. The unique benefit of being able to customize and “choose” their pseudophakic vision after the surgery will be understandable, desirable, and easily explained to family and friends.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
可调节IOL——颠覆屈光性IOL行业
可调节人工晶状体(IOL)是唯一的准备破坏屈光性人工晶状体领域的白内障和屈光性人工晶状体交换患者。这是因为它们不仅能改善屈光结果,还能极大地提高患者的体验。患者将能够推迟对屈光目标和物镜的混淆决定,直到他们可以在术后预览它们。手术后能够定制和“选择”他们的假性视力的独特好处将是可以理解的,可取的,并且很容易向家人和朋友解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
New and Emerging Trabecular Meshwork Bypass Stents Current and Emerging Therapies for Leber Hereditary Optic Neuropathy Safety and Efficacy of Suprachorodial Injection of Triamcinolone Acetonide: Review of a Novel Treatment Neurotrophic Keratitis: Exploring the Therapeutic Landscape iDose TR Sustained-release Travoprost Implant for the Treatment of Glaucoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1